Characterization of Synonymous BRCA1:c.132C>T as a Pathogenic Variant
Jun Li(Sun Yat-sen University), Yongjun Guo(Tianjin Agricultural University), Sile Han(Zhengzhou University), Hongle Li(Shanghai Jiao Tong University), Zhiyuan Liu(Shandong University), Jie Ma(Renal Research Institute), Bing Wei(Guangdong Medical College), Ping Wang(Beijing Institute of Technology), Weiling Liu(Zhengzhou University), Cuiyun Zhang(Zhengzhou University), Xiaoyan Wang(University of California, Los Angeles), Han Xiao(Rice University)
Cited by 2
Related Papers
MEK inhibitors for the treatment of non-small cell lung cancer
|Journal of Hematology & Oncology|2021|300
Recent Advance in Biological Responsive Nanomaterials for Biosensing and Molecular Imaging Application
|International Journal of Molecular Sciences|2022|217
Biomimetic Impact Protective Supramolecular Polymeric Materials Enabled by Quadruple H-Bonding
|Journal of the American Chemical Society|2020|191
SETD2: an epigenetic modifier with tumor suppressor functionality
|Oncotarget|2016|167
The Direct Asymmetric Vinylogous Aldol Reaction of Furanones with α‐Ketoesters: Access to Chiral γ‐Butenolides and Glycerol Derivatives
|Angewandte Chemie International Edition|2011|117